# MedManage Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medmanage-systems

- Industry: Healthcare
- Headquarters: Marlborough, US
- Website: www.medmanagesystems.com
- Total disclosed funding: $25M
- Latest round: Series E (Jul 31, 2007)
- Investors on record: 5

## About

MedManage Systems is a technology-driven company specializing in pharmaceutical sample distribution solutions, enhancing the efficiency of sample delivery to healthcare providers across the United States.Founded in 1999 in Marlborough, US, MedManage Systems focuses on streamlining the distribution of pharmaceutical samples. The company was acquired by Physicians Interactive in April 2009 for an undisclosed amount. The founder's history is not specified, and there are no mentions of subsidiaries or previous companies.MedManage Systems offers a suite of solutions centered on its core product, the Sample Center™, which manages the distribution of pharmaceutical samples. This platform enables clients to track requests, manage inventory, and ensure compliance. Primarily serving pharmaceutical companies and healthcare providers, it addresses critical needs in sample distribution within the North American market.MedManage Systems generates revenue through a transactional model, which includes partnerships and subscriptions for its Sample Center™ services. Fees are structured based on the volume of samples managed and distributed, with various pricing plans tailored to pharmaceutical companies' needs. This model supports direct access to samples, enhancing the customer experience.MedManage Systems plans to leverage recent funding from its Series E round, amounting to USD 5.00 mn, to expand into new markets and enhance its product offerings. There are indications of upcoming products designed to improve sample distribution efficiency, although specific release dates are not disclosed. The company aims to target additional regions within the healthcare sector for expansion, further utilizing the funding to support these initiatives.

## Funding rounds

- Series E, Jul 31, 2007, $5M — Prism Venture Management, Versant Ventures, Lilly Ventures, Questmark Management Company
- Series D, Mar 24, 2006, $11M — Prism Venture Management, Versant Ventures, Lilly Ventures, Questmark Management Company
- Series C, Apr 26, 2004, $6M — Prism Venture Management, Versant Ventures, Lilly Ventures
- Series B, Dec 12, 2002, $3.5M — Prism Venture Management, Tredegar Corporation

## Investors

- Prism Venture Management (https://capitalatlas.ai/funds/prism-venture-management) — Series B, Series C, Series D, Series E
- Tredegar Corporation — Series B
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series C, Series D, Series E
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series C, Series D, Series E
- Questmark Management Company (https://capitalatlas.ai/funds/questmark-management-company) — Series D, Series E